MY141221A - Casein hydrolyzate, process for producing the same, and use thereof - Google Patents
Casein hydrolyzate, process for producing the same, and use thereofInfo
- Publication number
- MY141221A MY141221A MYPI20044652A MY141221A MY 141221 A MY141221 A MY 141221A MY PI20044652 A MYPI20044652 A MY PI20044652A MY 141221 A MY141221 A MY 141221A
- Authority
- MY
- Malaysia
- Prior art keywords
- pro
- producing
- same
- hydrolysate
- casein hydrolyzate
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000005018 casein Substances 0.000 title 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 title 1
- 235000021240 caseins Nutrition 0.000 title 1
- 108010079058 casein hydrolysate Proteins 0.000 abstract 2
- 108010009736 Protein Hydrolysates Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
THE PRESENT INVENTION RELATES TO A CASEIN HYDROLYSATE CONTAININGFREE AMINOACIDSANDINVIVOINDIGESTIBLEPEPTIDESHAVINGMINIMALLYSUPPRESSEDINVIVOENZYMATICDIGESTIBILITY,ANDEXPECTEDTOEXPRESSFUNCTIONS,SUCHASHYPOTENSIVEEFFECT, IN LIVING ORGANISM, AND TO A METHOD FOR PREPARING SUCH A HYDROLYSATE, AND USE THEREOF. 'THE CASEIN HYDROLYSATE OF THEPRESENTINVENTJ,ONCONTAINSFREEAMINOACIDSANDPEPTIDES, SUCH AS IN VIVO INDIGESTIBLE PEPTIDES INCLUDING XAA-PRO ANDXAA-PRO-PRO, OBTAINEDBYHYDROLYZINGANIMALMILKCASEIN TO HAVE AN AVERAGE CHAIN LENGTH OF NOT LONGER THAN 2.1 IN TERMS OF THE NUMBER OF AMINO ACID RESIDUES, AND HAS ACE INHIBITORY ACTIVITY OR HYPOTENSIVE EFFECT.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI20044652 MY141221A (en) | 2004-11-09 | 2004-11-09 | Casein hydrolyzate, process for producing the same, and use thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI20044652 MY141221A (en) | 2004-11-09 | 2004-11-09 | Casein hydrolyzate, process for producing the same, and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY141221A true MY141221A (en) | 2010-03-31 |
Family
ID=47320754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20044652 MY141221A (en) | 2004-11-09 | 2004-11-09 | Casein hydrolyzate, process for producing the same, and use thereof |
Country Status (1)
| Country | Link |
|---|---|
| MY (1) | MY141221A (en) |
-
2004
- 2004-11-09 MY MYPI20044652 patent/MY141221A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA89616C2 (en) | Casein hydrolyzate, process for producing the same and use thereof | |
| SG131109A1 (en) | Muteins of tear lipocalin | |
| EP2455460A3 (en) | Lipase variants for pharmaceutical use | |
| NZ621196A (en) | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | |
| EP2085096A3 (en) | Novel composition and methods for the treatment of immune related diseases | |
| MX2008009493A (en) | Novel peptide and use thereof. | |
| WO2003064452A3 (en) | Method for the preparation of highly branched polypeptides | |
| WO2003075944A3 (en) | Interferon beta-like molecules for treatment of stroke | |
| EP2811030A3 (en) | Improved beta Thymosin fragments | |
| ITTO20000674A0 (en) | COMPOSITIONS BASED ON AMINO ACIDS, SUITABLE FOR THE TREATMENT OF HEART FAILURE. | |
| DE60036469D1 (en) | 17867, A HUMAN AMINO PEPTIDASE | |
| WO2005116658A3 (en) | Method for determining a tissue degradation process by detection of comp neoepitopes | |
| UA93658C2 (en) | Cell surface glycoprotein | |
| DE60015559D1 (en) | SENTRIN-SPECIFIC HUMAN PROTEASE SENP1 | |
| GB0228441D0 (en) | Splice variant | |
| SE0202608D0 (en) | New sequences | |
| WO2004056863A8 (en) | Splice variant of human placental growth hormone | |
| WO2002062845A3 (en) | Adhesion molecules | |
| WO2005087809B1 (en) | Peptides from vitronectin and their therapeutic exploitation for osteoblast adhesion | |
| WO2002010380A1 (en) | A novel polypeptide, a kruppel-like zinc finger protein zk110.12 and the polynucleotide encoding the polypeptide | |
| WO2000020572A3 (en) | Tissue binding peptides, identification, production and utilization thereof | |
| DE60112994D1 (en) | Human Cysteinyl Leukotriene Receptor 2 (CysLT2) |